Brain inflammation in early life has been proposed to play important roles in the development of neurodegenerative disorders in adult life. To test this hypothesis, we used a neonatal rat model of lipopolysaccharide (LPS) exposure (1000 EU/g body weight, intracerebral injection on P5) to produce brain inflammation. By P70, when LPS-induced behavioral deficits were spontaneously recovered, animals were challenged with rotenone, a commonly used pesticide, through subcutaneous mini-pump infusion at a dose of 1.25 mg/kg per day for 14 days. This rotenone treatment regimen ordinarily does not produce toxic effects on behaviors in normal adult rats. Our results show that neonatal LPS exposure enhanced the vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Rotenone treatment resulted in motor neurobehavioral impairments in rats with the neonatal LPS exposure, but not in those without the neonatal LPS exposure. Rotenone induced losses of tyrosine hydroxylase immunoreactive neurons in the substantia nigra and decreased mitochondrial complex I activity in the striatum of rats with neonatal LPS exposure, but not in those without this exposure. Neonatal LPS exposure with later exposure to rotenone decreased retrogradely labeled nigrostriatal dopaminergic projecting neurons. The current study suggests that perinatal brain inflammation may enhance adult susceptibility to the development of neurodegenerative disorders triggered later on by environmental toxins at an ordinarily non-toxic or sub-toxic dose. Our model may be useful for studying mechanisms involved in the pathogenesis of nonfamilial Parkinson's disease and the development of potential therapeutic treatments.
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Introduction
Nonfamilial Parkinson's disease (PD) is associated with advanced age, but it is still unclear whether dopaminergic neuronal death results from events initiated during development, adulthood, or represents a cumulative effect across the life span (Landrigan et al., 2005; Miller and O'Callaghan, 2008) . Perinatal or early life exposure to an endotoxin, lipopolysaccharide (LPS), has been shown to increase the risk of dopaminergic disorders in animal models of PD (Feleder et al., 2010; Ling et al., 2002 Ling et al., , 2004 Ling et al., , 2006 . We have recently reported that exposure to LPS (1 μg/g, intracerebral injection) during early development (postnatal day 5, P5) can produce lesions in the nigrostriatal dopaminergic system. Such a treatment also causes functional disability in juvenile rats, suggesting possible involvement of dopaminergic impairment in this neonatal rat model of central inflammation-induced neurological dysfunction (Fan et al., 2005b (Fan et al., , 2008b (Fan et al., , 2008c .
In this neonatal rat model, neonatal LPS exposure resulted in a chronic central inflammation, as evidenced by a sustained activation of microglia and an elevation of inflammatory cytokine levels in P70 LPS-exposed rat brain, as well as long-lasting injury to the dopaminergic system persisting into adult life (Fan et al., 2011) . However, as the rats aged, the neonatal LPS exposure-induced disturbances of motor behaviors in juvenile rats gradually improved and spontaneously recovered in adult rats (P70) (Fan et al., 2011) . These findings suggest that perinatal LPS exposure may produce a state of silent neurotoxicity in later life (Costa et al., 2004; Godfrey and Barker, 2001; Reuhl, 1991) as evidenced by the enhanced behavioral reaction upon methamphetamine administration to the animals (Fan et al., 2011; Fortier et al., 2004) . Other investigators have also reported that perinatal infection/inflammation-induced neurological impairments in animal models are not observable in adult life unless additional environmental insults or immune challenges occur in the adult (Bilbo et al., 2006; Fortier et al., 2004; Tenk et al., 2007) . If the theory of silent neurotoxicity is correct, existence of such a status may potentially enhance adult susceptibility to environmental factors Neurobiology of Disease 44 (2011) 304-316 
